Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH)

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|25|2|171-179

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.25, Iss.2, 2018-02, pp. : 171-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus–coinfected patients with mild fibrosis in the short term

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1503-1511

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus‐coinfected patients with compensated liver cirrhosis

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 228-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus–coinfected liver transplant recipients

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 2, 2015-02 ,pp. : 272-274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1136-1147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 794-796

John Wiley & Sons Inc

Access to resources Recommend Favorite